Top Markets
#1 BCGame Coin BCGame Coin +5.93%
#2 Tornado Cash Tornado Cash +5.13%
#3 Fake World Assets Fake World Assets +3.87%
#4 StonkBroker StonkBroker +2.14%
#5 Osmosis Osmosis +2.14%
#6 AtomOne AtomOne +2.05%
#7 aPriori aPriori +1.76%
#8 Nockchain Nockchain +1.73%
#9 Ether.fi Ether.fi +1.62%
#10 BORA BORA +1.46%
Coin of the day
BCGame Coin BCGame Coin
設定
言語
日本
通貨
USD
テーマ
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
株式のランク #25718
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
株価
$1.45
最終同期: 2026-08-19
時価総額
$46.94M
変化（1日）
0.00%
変化（1年）
-18.08%
国
US
取引 Vicapsys Life Sciences, Inc. (VICP)

カテゴリー

Healthcare
Vicapsys Life Sciences, Inc.（VICP）の配当利回りの履歴
Vicapsys Life Sciences, Inc.（銘柄コード: VICP）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Vicapsys Life Sciences, Inc.（VICP）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US